- What is the purpose of the study – is it to determine a new drug or suggest a new combination of drugs/treatment?
- Who has reviewed and approved the study?
- How are study results and safety of participants being checked?
- What kinds of therapies, procedures and/or tests will I have during the trial?
- How will the trial affect my current treatment plan and affect my daily life?
- Will I be taken off my current treatment or will I continue to take my regular medications while in the trial?
- Where will I have my medical care, and who will be in charge of my care?
- If the person in charge of my medical care during the trial is different from my current doctor, what will be the communication/interaction between the two?
- What are the benefits to my treatment and my health connected with this trial?
- What are the potential short-term and long term risks connected with this trial?
- Can I talk to other people in the study?
- What is the procedure for quitting the study once I have started it?
- Will there be costs to me if I participate?
- Will my insurance cover the costs?
- What are my responsibilities if I participate?
- How long will I be in the study?
Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.
The CDC recently announced that fewer than half of American children are given the HPV vaccination.
As of the July 23 deadline, 55 research abstracts were submitted in hopes of receiving one of only 6 grants from the Foundation. This points to a need for more funding so that the Foundation may award grants to every deserving applicant.